Search results
Results from the WOW.Com Content Network
[29] [92] [72] In a 2010 review examining whether weight stigma is an appropriate public health tool for treating and preventing overweight and obesity, Puhl and Heuer concluded that stigmatizing individuals with obesity is detrimental in three important ways: (1) it threatens actual physical health, (2) it perpetuates health disparities, and ...
According to the Centers for Disease Control and Prevention, nearly 80 percent of adults and about one-third of children now meet the clinical definition of overweight or obese. More Americans live with “extreme obesity“ than with breast cancer, Parkinson’s, Alzheimer’s and HIV put together.
Clayton and Byrd write that there have been two periods of health reform specifically addressing the correction of race-based health disparities. The first period (1865–1872) was linked to Freedmen's Bureau legislation and the second (1965–1975) was a part of the Civil Rights Movement. Both had dramatic and positive effects on black health ...
"Race-based medicine" is the term for medicines that are targeted at specific racial clusters which are shown to have a propensity for a certain disorder. The first example of this in the U.S. was when BiDil , a medication for congestive heart failure, was licensed specifically for use in American patients that self-identify as black. [ 60 ]
In the United States the number of children a person has had is related to their risk of obesity. A woman's risk of obesity increases by 7% per child, while a man's risk increases by 4% per child. [24] This could be partly explained by the fact that having dependent children decreases physical activity in Western parents. [25]
Based on data analysis done on a survey of over 3,000 Americans, weight and height discrimination, a form of sizeism, was ranked just behind gender, age, and race as a highly experienced factor of discrimination. Among female respondents, weight and height discrimination exceeds race-based discrimination as the third most prevalent form of ...
Share of adults that are obese, 1975 to 2016. Obesity is common in the United States and is a major health issue associated with numerous diseases, specifically an increased risk of certain types of cancer, coronary artery disease, type 2 diabetes, stroke, and cardiovascular disease, as well as significant increases in early mortality and economic costs. [1]
AstraZeneca moved on Thursday to boost its drugs pipeline in the booming anti-obesity market, saying it would pay China's Eccogene up to about $2 billion for an exclusive licence to develop an ...